DeepMed Research

St. Jude Children's Research Hospital

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1962-01-01

Employees: -

Market Cap: -

Website: http://www.stjude.org/

Clinical Trials

Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant

Completed

Conditions: Hematopoietic Stem Cell Transplantation

Interventions: Other: Data Collection

First Posted Date: 2008-05-08

Last Posted Date: 2024-12-18

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 637

Registration Number: NCT00674882

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Bone Marrow for Hemoglobinopathy Research

Completed

Conditions: Sickle Cell Anemia
Thalassemia

First Posted Date: 2008-04-30

Last Posted Date: 2020-02-25

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 26

Registration Number: NCT00669305

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Prospective Surveillance For Respiratory Virus Infections In Children Undergoing Hematopoietic Stem Cell Transplantation

Completed

Conditions: Respiratory Virus Infections

Interventions: Other: Nasopharyngeal Washes
Other: Fluorescent antibody detection
Other: Respiratory viral culture

First Posted Date: 2008-04-28

Last Posted Date: 2012-09-07

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 51

Registration Number: NCT00667303

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission

Phase 1

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Busulfan
Drug: Cyclophosphamide
Drug: Mesna

First Posted Date: 2008-04-28

Last Posted Date: 2008-04-28

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 17

Registration Number: NCT00667927

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma

Phase 2

Completed

Conditions: Malignant Fibrous Histiocytoma (MFH) of Bone
Osteosarcoma

Interventions: Biological: Bevacizumab
Drug: Cisplatin
Drug: Doxorubicin
Drug: Methotrexate
Procedure: Surgery
Drug: Ifosfamide
Drug: etoposide
Radiation: Radiotherapy

First Posted Date: 2008-04-28

Last Posted Date: 2023-08-07

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 43

Registration Number: NCT00667342

Locations: 🇺🇸
Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
NCI/NIH - Pediatric Oncology Branch, Bethesda, Maryland, United States

and more 2 locations

A Pilot Study to Examine Sleep and Fatigue in Pediatric Brain Tumor Patients Hospitalized for High Dose Chemotherapy

Not Applicable

Completed

Conditions: Fatigue
Sleep

Interventions: Other: Sleep Environment Intervention
Other: Normal Hospital Environment

First Posted Date: 2008-04-25

Last Posted Date: 2019-08-19

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 43

Registration Number: NCT00666614

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Pilot Test for a Newly Developed Nutrition Screening Method: Pediatric Subjective Global Assessment

Completed

Conditions: Compare Two Nutrition Screening Tools

Interventions: Other: Nutritional Screening Tools

First Posted Date: 2008-04-24

Last Posted Date: 2017-04-26

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 132

Registration Number: NCT00665691

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia

Phase 1

Completed

Conditions: Refractory Solid Tumors
Leukemia

Interventions: Drug: Bevacizumab
Drug: Sorafenib
Drug: Cyclophosphamide

First Posted Date: 2008-04-24

Last Posted Date: 2015-01-09

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 49

Registration Number: NCT00665990

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia Survivors

Completed

Conditions: Acute Lymphoblastic Leukemia

Interventions: Other: Neurological Examination/Questionnaires

First Posted Date: 2008-04-22

Last Posted Date: 2011-09-23

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 165

Registration Number: NCT00664131

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors

Phase 1

Completed

Conditions: Leukemia, Myeloid, Acute
T-cell Lymphoblastic Lymphoma
Myelodysplastic Syndrome
Leukemia, Lymphocytic, Acute, T-Cell
Juvenile Myelomonocytic Leukemia Lymphoblastic

Interventions: Procedure: Haploidentical donor derived natural killer cell infusion
Drug: Chemotherapy
Device: CliniMACS

First Posted Date: 2008-03-21

Last Posted Date: 2014-04-24

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 22

Registration Number: NCT00640796

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy